Abeona Therapeutics Inc. has entered into a securities purchase agreement to issue and sell 3,284,407 shares of its common stock and pre-funded warrants to buy 2,919,140 shares of its common stock to certain institutional investors. The common shares are priced at $4.03 each and the pre-funded warrants are priced at $4.0299 each, totalling around $22.9 million in net proceeds.